💊 Tamoxifen (Tamoxifen Citrate)
Tamoxifen is an oral medicine used to treat breast cancer in women and men and to reduce the risk of breast cancer in women at high risk. It is prescribed by a doctor, who sets the dose and duration of treatment for your condition.
In Arabic: تاموكسيفين✅ What it is used for
- Treatment of metastatic breast cancer in women and men
- Adjuvant treatment of node-positive breast cancer in postmenopausal women after surgery and breast irradiation
- Adjuvant treatment of node-negative breast cancer in women after surgery and breast irradiation
- Reducing contralateral breast cancer in patients receiving adjuvant therapy
- Reducing the risk of invasive breast cancer in women with ductal carcinoma in situ (DCIS) after surgery and radiation
- Reducing the incidence of breast cancer in women at high risk
🧪 Active ingredient
Tamoxifen citrate: a nonsteroidal antiestrogen that competes with estrogen for binding sites in target tissues such as breast and binds estrogen receptors in tumor cells.
🌿 Benefits
- Effective in treating metastatic breast cancer in women and men
- An alternative to oophorectomy or ovarian irradiation in premenopausal women with metastatic breast cancer
- Patients with estrogen receptor positive tumors are more likely to benefit
- Reduces occurrence of contralateral breast cancer
- Reduces risk of invasive breast cancer in DCIS and in high-risk women
📝 How to use
- Take by mouth exactly as directed by your doctor or pharmacist.
- The doctor sets the dose and duration; do not change the dose or stop on your own.
- Doses above 20 mg per day are usually divided into morning and evening doses.
- Clinical trial data support 5 years of therapy for breast cancer and for risk reduction.
- A Medication Guide should be dispensed with each prescription; read it carefully.
💊 Dosage forms
- 10 mg tablets
- 20 mg tablets
⚠️ Common side effects
- Hot flashes
- Vaginal discharge
- Irregular menses or amenorrhea
- Fluid retention and peripheral edema
- Nausea
- Skin changes
- Weight loss
- Fatigue
- Vaginal dryness
- Dizziness and headache
- Hair thinning or partial hair loss
- Bone or tumor pain and local disease flare early in treatment
🚨 Serious — seek medical help
- Uterine malignancies (endometrial cancer and uterine sarcoma), some fatal
- Stroke
- Pulmonary embolism
- Thrombotic events including deep vein thrombosis
- Hypercalcemia in patients with bone metastases
- Increased liver enzymes and bilirubin
- Loss of libido and impotence in men
⛔ Do not use if
- Known hypersensitivity to the drug or any of its ingredients
- Women who require concomitant coumarin-type anticoagulant therapy (in risk reduction and DCIS settings)
- Women with a history of deep vein thrombosis or pulmonary embolus (in risk reduction and DCIS settings)
❗ Warnings & precautions
- Boxed warning: in the risk reduction setting (women at high risk or with DCIS), serious and life-threatening events include uterine malignancies, stroke and pulmonary embolism.
- Discuss the benefits and risks with your doctor before starting therapy for risk reduction.
- The benefits of tamoxifen outweigh its risks in women already diagnosed with breast cancer.
- Hypercalcemia may occur within weeks of starting treatment in patients with bone metastases; if severe, tamoxifen should be discontinued.
- Uterine malignancies are increased with tamoxifen; uterine sarcoma is reported more often with long-term use (2 years or more).
- Report any abnormal vaginal bleeding or symptoms of a clot or stroke to your doctor.
- Pregnancy Category D (see Pregnancy).
🔄 Drug interactions
- Coumarin-type anticoagulants: anticoagulant effect may increase significantly; monitor prothrombin time
- Cytotoxic agents: increased risk of thromboembolic events when combined
- Letrozole: tamoxifen reduced letrozole plasma concentrations by 37%
- Rifampin and aminoglutethimide: reduce tamoxifen and N-desmethyl tamoxifen concentrations
- Phenobarbital: associated with a lower tamoxifen steady-state level in one patient
- Medroxyprogesterone: reduces N-desmethyl tamoxifen concentrations
- Bromocriptine: elevates tamoxifen and N-desmethyl tamoxifen levels
- Anastrozole: tamoxifen should not be administered with it
🤰 Pregnancy
Tamoxifen is Pregnancy Category D (evidence of fetal risk). Tell your doctor immediately if you are pregnant or planning pregnancy; use only under medical supervision.
🍼 Breastfeeding
Tamoxifen has been reported to inhibit lactation, and it is not known whether it is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants, women taking tamoxifen should not breast-feed.
🧒 Children
Safety and efficacy in girls aged 2 to 10 years with McCune-Albright Syndrome and precocious puberty have not been studied beyond one year of treatment, and long-term effects are not established. Use in children only under specialist supervision.
👴 Older adults
No overall differences in tolerability were observed between older and younger patients in the studies described in the label. Consult your doctor for individual assessment.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F). Avoid excessive heat (over 40°C/104°F). Protect from light; keep in a tight, light-resistant container with a child-resistant closure, out of reach of children.
⏰ Missed dose
The label does not give instructions for a missed dose. Ask your doctor or pharmacist what to do, and do not double a dose on your own.
🆘 Overdose
Acute overdosage in humans has not been reported. In very-high-dose studies, tremor, hyperreflexia, unsteady gait, dizziness and QT prolongation were noted. There is no specific treatment; treatment is symptomatic. If overdose is suspected, contact emergency services or a poison center immediately.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Nonsteroidal antiestrogen (triphenylethylene derivative) that competes with estrogen for receptor binding in target tissues such as breast, and competes with estradiol for estrogen receptor protein in cytosols of human breast adenocarcinomas.
Labeled dosing
Adults with breast cancer: recommended daily dose 20 to 40 mg; doses above 20 mg/day should be divided (morning and evening). DCIS and risk reduction in high-risk women: 20 mg daily for 5 years. The final dose is determined by the prescriber.
- Absorption: peak plasma concentration about 40 ng/mL approximately 5 hours after a single 20 mg dose.
- Terminal half-life about 5 to 7 days; steady state in about 4 weeks for tamoxifen and about 8 weeks for N-desmethyl tamoxifen.
- Extensively metabolized; N-desmethyl tamoxifen is the major metabolite.
- One 20 mg tablet once daily was bioequivalent to 10 mg tablets twice daily.
- Monitor prothrombin time with coumarin-type anticoagulants.
- Do not coadminister with anastrozole; tamoxifen reduced letrozole concentrations by 37%.
- No data support use beyond 5 years.
🎓 Key points for students
- Tamoxifen is a nonsteroidal antiestrogen used in estrogen receptor positive breast cancer.
- Serious effects linked to its estrogen-like activity include endometrial cancer, uterine sarcoma and thromboembolism.
- Key interactions: coumarins (increased effect) and CYP3A4 inducers such as rifampin (reduced levels).
- Pregnancy Category D; breastfeeding should be avoided during treatment.
- Recommended adjuvant duration is 5 years based on clinical data.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is tamoxifen used for?
It is used to treat breast cancer in women and men and to reduce the risk of breast cancer in women at high risk or with DCIS.
How long is tamoxifen treatment?
Clinical data support 5 years of therapy for breast cancer and risk reduction, but your doctor determines the right dose and duration for you.
What are the common side effects?
The most common include hot flashes, vaginal discharge, irregular menses, fluid retention and nausea.
Can it be used in pregnancy or breastfeeding?
It is Pregnancy Category D, and women taking it should not breast-feed. Consult your doctor.
Does tamoxifen interact with other drugs?
Yes, notably coumarin-type anticoagulants, rifampin, letrozole and anastrozole. Tell your doctor about all your medicines.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2021-07), simplified. Updated: 2026-11-15.